Wednesday, June 22nd, 2022

Helpathon: £10,000 available for pilot study grants

Deadline 30 June

The Alliance for Human Relevant Science and Animal Free Research UK are teaming up with members of the Dutch TPI Helpathon initiative to bring the first Helpathon to the UK on 11 and 12 October.

Helpathons are used in the Netherlands to help researchers who might otherwise undertake animal experiments to make the shift towards animal free methods.

The deadline for expressions of interest is 30 June 2022.

Researchers should send a short summary of their research interests and what they would like to achieve from the Helpathon to katharine@animalfreeresearchuk.org

For more information, please visit www.animalfreeresearchuk.org/helpathon

Wednesday, May 25th, 2022

UK’s first Helpathon to accelerate human-relevant science announced

The Alliance for Human Relevant Science and Animal Free Research UK have teamed up with Dutch partners from the Transition Programme for Innovation to launch Britain’s first Helpathon.

Helpathons are used in the Netherlands to help researchers who might otherwise undertake animal experiments to make the shift towards animal free methods.

Carla Owen, Chair of the Alliance for Human Relevant Science and CEO of Animal Free Research UK said “The arrival of the project in Britain will help the country’s scientists transition away from outdated animal-based medical research methods and grasp a human-relevant future.”

TPI Helpathon team member Pepik Henneman, said: “A Helpathon invites anyone to ask a question to help resolve a societal issue. We will invite medical researchers to ask how they can innovate their research methods in an animal free way.”

Prof Sue Gibbs of the Amsterdam University Medical Centre and TPI Helpathon team member, said: “By obtaining advice and eliciting answers from trail blazing scientists already using human-focused methods, our Helpathons are undoubtedly shifting mindsets and making it easier to transition to human relevant science.”

The first UK Helpathon will be hosted by the Alliance for Human Relevant Science on 11 and 12 October.

Owen added: “All research scientists are invited to become involved in the project. Our Helpathon is the next step in the innovation wave that is transforming medical research in the UK and beyond.”

Owen is currently chair of the Alliance for Human Relevant Science, an inclusive collaboration of like-minded companies, organisations and individuals. Working together, the Alliance aims to improve awareness of the transformative potential of human-focused research tools and increase their use to improve public health.

For more information, please contact or visit www.animalfreeresearchuk.org/helpathon

Notes to Editors: 

Animal Free Research UK CEO, and chair of The Alliance for Human Relevant Science Carla Owen, is available for interviews about the Helpathon.   Please contact Animal Free Research UK Media and PR Manager Peter Simpson peter@animalfreeresearchuk.org : Tel (+44) 07803 051 848

Animal Free Research UK funds pioneering research that saves humans and animals and is forging a future where animals are replaced with modern, human relevant techniques. With over 92 percent of new drugs tested on animals failing to benefit human health, the charity recognises that a transition to animal-free human-relevant technology will help position the UK as a science powerhouse. For more information visit www.animalfreeresearchuk.org/

The Alliance for Human Relevant Science is an inclusive collaboration of like-minded companies, organisations and individuals. Working together, we will accelerate innovation and create positive change.  Click here to find out more Who we are – Human Relevant Science

Tuesday, March 22nd, 2022

APPG REPORT LAUNCH

On Tuesday 22nd March 2022, Grahame Morris MP hosted the publication of the APPG for Human Relevant Science’s new report “Bringing Back the Human: Transitioning from Animal Research to Human Relevant Science in the UK” at the Houses of Parliament, Westminster, London.

The report makes the case that the UK’s system for funding research and innovation is holding back the discovery and development of new medicines and treatments to meet today’s health challenges. MPs called for a new government Minister for Human Relevant Science to drive the transition to human relevant science necessary to advance treatments for diseases.

Read the full report and a summary here.

Friday, April 23rd, 2021

Third APPG on human relevant science

The third APPG on human relevant sciences will be held (virtually) on the Wednesday 12th May 2021 at 3 – 4.30pm UK time where we will continue to gather evidence of funding sources and gaps for human relevant approaches in the UK.

Our final meeting will focus on defining changes required in regulations (Sept 2021) in order for these methods to be more widely adopted. A report of our findings will be available in Nov 2021. Call back here after the 12th May 2021 to hear what was discussed at the third meeting.

Click here for more info

Wednesday, January 13th, 2021

Next APPG meeting date confirmed.

Our second APPG meeting will be held (virtually) on Tuesday 9th February at 4pm UK time, where we will start the process of examining whether the current regulatory framework is designed to promote the implementation and adoption of human relevant technologies in the  UK.

Future meetings will focus on defining changes required in funding (May 2021) and regulations (Sept 2021) in order for these methods to be more widely adopted. A report of our findings will be available in Nov 2021. Call back here after the 9th February 2021 to hear what was discussed at the second meeting!

Click here for more info.

Monday, January 11th, 2021

CN Bio’s PhysioMimix™ technology receives FDA recognition

Alliance member CN Bio announces how a joint publication with the FDA demonstrates the advantages of their PhysioMimix™ in drug safety and metabolism applications, over standard techniques. This represents the first co-published, peer-reviewed article between a microphysiological system provider and a regulator:

Tuesday, October 6th, 2020

PRESS RELEASE New Parliamentary group calls for human relevant science moonshot

Tuesday 6 October, London: A new All-Party Parliamentary Group today held its first AGM with the aim of accelerating the development and uptake of human relevant life sciences in the UK.

The APPG on Human Relevant Science held its first meeting remotely on Tuesday 6 October, where the group outlined its priorities.

The APPG will be a discussion forum for politicians, the human relevant life sciences sector, third sector groups, scientists and stakeholders to promote new approach methodologies that provide unique insights into human biology, transform our ability to understand human disease and can develop effective new medicines more quickly and without the use of animals.

Its programme will cover the themes of strategic funding to incentivise the development and use of human relevant methods and technologies, and incorporation of human relevant methods into regulatory guidelines on medicines development.

The APPG’s statement of purpose is to bring together MPs and Peers of all parties to accelerate the development and uptake of human relevant life sciences in the UK.

Replacing poorly performing animal tests with innovative human relevant new approach methodologies will directly benefit the UK science base and enhance the efficiency and profitability of industries that make vital contributions to the UK economy.

Speaking at the launch, the APPG’s Chair, Labour MP Grahame Morris, said, “I am delighted to Chair the new All-Party Parliamentary Group on Human Relevant Science. The COVID-19 pandemic has demonstrated that the current approach to developing new treatments is simply not fast enough to meet humanity’s needs. We urgently need a moonshot to transition to new approach methodologies which promise to deliver safer and more effective medicines, more quickly and at less cost.”

APPG Vice Chair Conservative MP Sir David Amess said, “I am thrilled to be Vice Chair of the new All-Party Parliamentary Group on Human Relevant Science. With the cancellation of the Autumn Budget, the Government now has more time to think about what it can do to provide much-needed financial support to boost growth in the human relevant life sciences sector and enable the UK to remain an innovative science superpower.

“As the country seeks a COVID-19 vaccine, this is the perfect time for parliamentarians to take seriously the growing evidence in favour of the pioneering human relevant medical research techniques that are replacing the outdated use of animals.”

The Alliance for Human Relevant Science acts as the group’s secretariat.

ENDS

For more information please contact the Cruelty Free International media office;

email: media@crueltyfreeinternational.org  or telephone: +44 (0) 7590055 206.

NOTES

About the Alliance for Human Relevant Science

The Alliance for Human Relevant Science is an inclusive collaboration of like-minded companies, organisations and individuals, working together to show how significant advances in science and technology can deliver new methods based on human biology, with the potential to improve the safety of medicines and other chemicals.

 

Friday, March 20th, 2020

WHITEPAPER LAUNCH

On Tuesday 10th March 2020, Grahame Morris MP hosted the launch of our new whitepaper “Accelerating the Growth of Human Relevant Life Sciences in the United Kingdom” at Portcullis House, Westminster, London. MPs and scientists were able to discuss how significant advances in science and technology have delivered new methods based on human tissues and cells and have the potential to improve the prediction of human toxicities caused by medicines and other chemicals. Read the full whitepaper and a summary here.

Tuesday, March 10th, 2020

Accelerating the Growth of Human Relevant Life Sciences in the United Kingdom

The Alliance for Human Relevant Science, calls for a fresh approach to biomedical research and drug discovery.

New approach methodologies (NAMs) that are human relevant have the potential to improve the efficiency of drug research and development and to deliver safer, cheaper and more effective medicines to patients.

In the released White paper ‘Accelerating the Growth of Human Relevant Life Sciences in the United Kingdom’, the Alliance calls for support from the Government to assist businesses in the transition to NAMs by providing supportive infrastructure, strategic funding, education, collaboration between industries and regulatory engagement.

There is an opportunity for the UK to be a world leader in developing and evaluating NAMs. Investment in human relevant methods is good for both business and public health.

Read the White Paper summary document
Read the full paper